Citation: | Yisilamujiang·TUERXUN, LI Yuanming, Yelibo·JUNUSIHAN, LIU Wenjuan, ZOU Anqing, Mayirimu·SAIMAITI, CHEN Jiahua. Relationships of coagulation and fibrinolytic functions with patent foramen ovale complicated with cryptogenic stroke[J]. Journal of Clinical Medicine in Practice, 2023, 27(21): 116-119, 124. DOI: 10.7619/jcmp.20231661 |
To analyze the correlations of coagulation and fibrinolytic functions with patent foramen ovale complicated with cryptogenic stroke.
A total of 100 patients with patent foramen ovale and cryptogenic stroke from January 2020 to December 2022 were selected as observation group, and 100 patients with simple patent foramen ovale were selected as control group. Routine anticoagulant indicators and molecular markers of coagulation and fibrinolysis were detected in both groups; the multivariate Logistic regression model was used to analyze the correlations of coagulation and fibrinolytic function indicators with patent foramen ovale complicated with cryptogenic stroke; receiver operating characteristic (ROC) curve was used to analyze the efficiency of coagulation and fibrinolytic function indicators in predicting cryptogenic stroke inpatients with patent foramen ovale.
Levels of plasma D-dimer (D-D), fibrinogen lysate (FDP), thrombomodulin (TM), thrombin-antithrombin Ⅲ complex (TAT), plasminase-α2 plasminase inhibitor complex (PIC) and tissue plasminogen activator inhibitor-1 complex (t-PAIC) in the observation group were significantly higher than those in the control group (P < 0.05); the Multiple Logistic regressionanalysis showed that D-D, FDP, TM, TAT, PIC and t-PAIC were the independent predictors for cryptogenic stroke in patients with patent foramen ovale (P < 0.05); the ROC curve analysis showed the values of area under the curve (AUC) of D-D, FDP, TM, TAT, PIC and t-PAIC in predicting the onset of cryptogenic stroke in patients with patent foramen ovale were 0.665, 0.680, 0.835, 0.710, 0.680 and 0.752 respectively.
Patients with patent foramen ovale and cryptogenic stroke have enhanced coagulation and fibrinolytic functions, and early monitoring of coagulation and fibrinolytic functions can help predict cryptogenic stroke.
[1] |
周娣, 马小静, 熊青峰, 等. 双源冠状动脉CT血管造影在卵圆孔未闭诊断中的价值分析[J]. 中国循环杂志, 2022, 37(9): 935-939. doi: 10.3969/j.issn.1000-3614.2022.09.011
|
[2] |
RACHARLA L, KHER A, PATEL Z, et al. The hype surrounding patent foramen ovale closure and cryptogenic stroke: a walk through history[J]. Heart Int, 2022, 16(1): 59-63. doi: 10.17925/HI.2022.16.1.59
|
[3] |
李慧珠, 周树虎. 卵圆孔未闭患者的隐源性卒中: 潜在机制和预防策略[J]. 国际脑血管病杂志, 2021, 29(6): 448-451. doi: 10.3760/cma.j.issn.1673-4165.2021.06.009
|
[4] |
LIN T Y, FU Y C, JAN S L, et al. Detecting patent foramen ovale after cryptogenic stroke - A single center experience in Taiwan [J]. Acta Cardiol Sin, 2022, 38(3): 373-380.
|
[5] |
何权瀛. 卵圆孔未闭在阻塞性睡眠呼吸暂停引发的多种脑血管疾病中的作用[J]. 中华医学杂志, 2020, 100(36): 2808-2812. doi: 10.3760/cma.j.cn112137-20200604-01772
|
[6] |
LU J P, LI J G, HUANG H P, et al. Diagnostic value of micro-bubble transcranial Doppler combined with contrast transthoracic echocardiography in cryptogenic stroke patients with patent foramen ovale[J]. Neurol India, 2022, 70(4): 1403-1406. doi: 10.4103/0028-3886.355122
|
[7] |
曹月诚, 羡海英, 石秋林, 等. 卵圆孔未闭合并隐匿性卒中患者临床特点和危险因素分析[J]. 上海医学, 2020, 43(11): 670-674. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYX202011009.htm
|
[8] |
WINTZER-WEHEKIND J, ALPERI A, HOUDE C, et al. Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism[J]. J Am Coll Cardiol, 2019, 73(3): 278-287. doi: 10.1016/j.jacc.2018.10.061
|
[9] |
王豪, 孙园园, 邓雅琴, 等. 隐源性缺血性脑卒中合并卵圆孔未闭的临床及影像学检查分析[J]. 中国现代医学杂志, 2019, 29(1): 67-70. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY201901014.htm
|
[10] |
HVIID C V B, SIMONSEN C Z, HVAS A M. Recurrence risk in patients with cryptogenic stroke, patent foramen ovale, and thrombophilia: a systematic review and meta-analysis[J]. Thromb Haemost, 2019, 119(11): 1839-1848. doi: 10.1055/s-0039-1693739
|
[11] |
简鹿豹, 黄珊珊, 王芙蓉, 等. 伴卵圆孔未闭的隐源性脑卒中的临床表现及影像学特征[J]. 卒中与神经疾病, 2020, 27(2): 156-160. doi: 10.3969/j.issn.1007-0478.2020.02.003
|
[12] |
郭俊, 许强宏. 脓毒症患者血栓调节蛋白和纤溶酶原激活物抑制剂-1及内皮细胞损伤程度的研究初探[J]. 中华内科杂志, 2021, 60(2): 143-146.
|
[13] |
张伯玮, 任静, 张珠博, 等. 创伤性脑损伤患者凝血酶-抗凝血酶复合物持续增高预示不良临床结局[J]. 中华检验医学杂志, 2021, 44(5): 402-407.
|
[14] |
GONZALEZ J B, TESTAI F D. Advances and ongoing controversies in patent foramen ovale closure and cryptogenic stroke[J]. Neurol Clin, 2021, 39(1): 51-69.
|
[15] |
D′ANDREA A, DWECK M R, HOLTE E, et al. EACVI survey on the management of patients with patent foramen ovale and cryptogenic stroke[J]. Eur Heart J Cardiovasc Imaging, 2021, 22(2): 135-141.
|
[16] |
孟森, 李玉方, 康宪政. 血液标志物在卵圆孔未闭相关隐源性卒中中的表达特点和临床价值[J]. 中国实验诊断学, 2022, 26(3): 349-352. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZD202203009.htm
|
[17] |
付阳, 刘玉梅, 金亚雄, 等. 凝血与纤溶标志物在肺癌血栓栓塞患者中的临床应用价值研究[J]. 中国肺癌杂志, 2018, 21(8): 583-587. https://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ201808003.htm
|
[18] |
ZHU Y, ZHANG J, HUANG B, et al. Impact of patent foramen ovale anatomic features on right-to-left shunt in patients with cryptogenic stroke[J]. Ultrasound Med Biol, 2021, 47(5): 1289-1298.
|
1. |
张敏,李莎妮,喻楷权,吴济丽,陈宇琪,杨建波,蔡伟. 基于网络药理学与分子对接技术新疆阿魏抗癌作用机制探讨. 药物评价研究. 2023(04): 728-737 .
![]() |